-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
On July 2, Prolog Pharmaceuticals announced that Zhejiang Yosemite Chinese Medicine, a wholly-owned subsidiary, received the "Drug Registration Approval Document" for Ubenimex Capsules approved and issued by the National Medical Products Administration
Ubenimex is an immunomodulatory drug and an antitumor drug
Up to now, the company has invested about 6.